Infliximab: a promising alternative therapy for refractory arthritis/urethritis/conjunctivitis triad

Isr Med Assoc J. 2009 Aug;11(8):511-3.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis, Reactive / complications
  • Arthritis, Reactive / drug therapy*
  • Conjunctivitis / complications
  • Conjunctivitis / drug therapy*
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Urethritis / complications
  • Urethritis / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab